The genetic basis of Gilles de la Tourette Syndrome

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 6, 2013, Pages 1026-1039

  Paschou, Peristera ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Genetics; Gilles de la Tourette Syndrome; Neurodevelopmental disorders

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMIC ACID; HISTAMINE; HISTIDINE DECARBOXYLASE; NEUREXIN; AMINE OXIDASE (FLAVIN CONTAINING); MEMBRANE PROTEIN; NERVE PROTEIN; SLITRK1 PROTEIN, HUMAN;

AUTISM; CHROMOSOME ABERRATION; CNTNAP2 GENE; COPY NUMBER VARIATION; DAT1 GENE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRD2 GENE; GENE; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMMP2L GENE; MAO A GENE; NEUROLIGIN 4 GENE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SHORT TANDEM REPEAT; SLITRK1 GENE; GENETIC PREDISPOSITION; GENETICS; TOURETTE SYNDROME;

CHROMOSOME ABERRATIONS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MEMBRANE PROTEINS; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D2; TOURETTE SYNDROME;

EID: 84891893445     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.01.016     Document Type: Review

References (205)

1. Abelson J.F., Kwan K.Y., O'roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., Mathews C.A., Pauls D.L., Rasin M.R., Gunel M., Davis N.R., Ercan-Sencicek A.G., Guez D.H., Spertus J.A., Leckman J.F., Dure L.S., Kurlan R., Singer H.S., Gilbert D.L., Farhi A., Louvi A., Lifton R.P., Sestan N., State M.W. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
2. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(45):17849-17854. (Epub 2007 October 31).
3. Adamczyk A., Gause C.D., Sattler R., Vidensky S., Rothstein J.D., Singer H., Wang T. Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome. Psychiatric Genetics 2011, 21(2):90-97.
4. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends in Neurosciences 2006, 29(3):175-182.
5. Aliane V., Pérez S., Bohren Y., Deniau J.M., Kemel M.L. Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies. Brain 2010, 134:110-118.
6. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Archives of Internal Medicine 2005, 165(11):1286-1292.
7. Anderson G.M., Pollak E.S., Chatterjee D., Leckman J.F., Riddle M.A., Cohen D.J. Archives of General Psychiatry 1992, 49:584-586.
8. Anney R., Klei L., Pinto D., et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Human Molecular Genetics 2012, 21(21):4781-4792.
9. Arnold P.D., Sicard T., Burroughs E., Richter M.A., Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder?. Archives of General Psychiatry 2006, 63(7):769-776.
10. Arroyo E.J., Xu T., Poliak S., Watson M., Peles E., Scherer S.S. Internodal specializations of myelinated axons in the central nervous system. Cell and Tissue Research 2001, 305:53-66.
11. Aruga J., Mikoshiba K. Identification and characterization of Slitrk a novel neuronal transmembrane protein family controlling neurite outgrowth. Molecular and Cellular Neurosciences 2003, 24(1):117-129.
12. Baron M., Shapiro E., Shapiro A., Rainer J.D. Genetic analysis of Tourette syndrome suggesting major gene effect. American Journal of Human Genetics 1981, 33:767-775.
13. Baron-Cohen S., Scahill V.L., Izaguirre J., Hornsey H., Robertson M.M. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study?. Psychological Medicine 1999, 29(5):1151-1159.
14. Barr C.L., Wigg K.G., Zovko E., Sandor P., Tsui L.C. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families?. American Journal of Medical Genetics 1996, 67(3):301-305.
15. Barr C.L., Wigg K.G., Pakstis A.J., Kurlan R., Pauls D., Kidd K.K., Tsui L.C., Sandor P. Genome scan for linkage to Gilles de la Tourette syndrome. American Journal of Medical Genetics 1999, 88(4):437-445.
16. Belloso J.M., Bache I., Guitart M., Caballin M.R., Halgren C., Kirchhoff M., Ropers H.H., Tommerup N., Tümer Z. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. European Journal of Human Genetics 2007, 15(June (6)):711-713. (Epub 2007 March 28).
17. Bienvenu O.J., Wang Y., Shugart Y.Y., Welch J.M., Grados M.A., Fyer A.J., Rauch S.L., McCracken J.T., Rasmussen S.A., Murphy D.L., Cullen B., Valle D., Hoehn-Saric R., Greenberg B.D., Pinto A., Knowles J.A., Piacentini J., Pauls D.L., Liang K.Y., Willour V.L., Riddle M., Samuels J.F., Feng G., Nestadt G. Sapap3 and pathological grooming in humans: results from theOCD collaborative genetics study. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2009, 150B(5):710-720.
18. Bloch M.H., Leckman J.F. Clinical course of Tourette syndrome. Journal of Psychosomatic Research 2009, 67(6):497-501.
19. Boghosian-Sell L., Comings D.E., Overhauser J. Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. American Journal of Human Genetics 1996, 59(November (5)):999-1005.
20. Breedveld G.J., Fabbrini G., Oostra B.A., Berardelli A., Bonifati V. Tourette disorder spectrum maps to chromosome 14q31.1 in an Italian kindred. Neurogenetics 2010, 11(4):417-423.
21. Brett P.M., Curtis D., Robertson M.M., Gurling H.M. The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biological Psychiatry 1995, 37(8):533-540.
22. Burd L., Freeman R.D., Klug M.G., Kerbeshian J. Tourette syndrome and learning disabilities. BMC Pediatrics 2005, 5:34.
23. Casey J.P., Magalhaes T., Conroy J.M., et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Human Genetics 2012, 131(April (4)):565-579.
24. Chappell P., Leckman J., Goodman W., et al. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biological Psychiatry 1996, 39:776-783.
25. Chou I.C., Tsai C.H., Lee C.C., Kuo H.T., Hsu Y.A., Li C.I., Tsai F.J. Association analysis between Tourette's syndrome and dopamine D1 receptor gene in Taiwanese children?. Psychiatric Genetics 2004, 14(4):219-221.
26. Chou I.C., Wan L., Liu S.C., Tsai C.H., Tsai F.J. Pediatric Neurology 2007, 37(6):404-406.
27. Chou I.C., Lin H.C., Wang C.H., Lin W.D., Lee C.C., Tsai C.H., Tsai F.J. Polymorphisms of interleukin 1 gene IL1RN are associated withTourette syndrome?. Pediatric Neurology 2010, 42(5):320-324.
28. Clarke R.A., Fang Z.M., Diwan A.D., Gilbert D.L. Tourette syndrome and klippel-feil anomaly in a child with chromosome 22q11 duplication. Case Report Med 2009, 2009:361518.
29. Coffey B.J., Biederman J., Smoller J.W., et al. Anxiety disorders and tic severity in juveniles with Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:562-568.
30. Cohen D.J., Shaywitz B.A., Caparulo B., Young J.G., Bowers M.B. Archives of General Psychiatry 1978, 35:245-250.
31. Comings D.E., Comings B.G., Muhleman D., Dietz G., Shahbahrami B., Tast D., Knell E., Kocsis P., Baumgarten R., Kovacs B.W., et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders?. Journal of the American Medical Association 1991, 266(13):1793-1800.
32. Comings D.E., Muhleman D., Dietz G., Dino M., LeGro R., Gade R. Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet 1993, 341(8849):906.
33. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., MacMurray J.P., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and D AT1. American Journal of Medical Genetics 1996, 67:264-288.
34. Comings D.E., Gonzalez N., Wu S., Gade R., Muhleman D., Saucier G., Johnson P., Verde R., Rosenthal R.J., Lesieur H.R., Rugle L.J., Miller W.B., MacMurray J.P. Studies of the 48bp repeat polymorphism of the DRD4 gene in impulsive compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. American Journal of Medical Genetics 1999, 88(4):358-368.
35. Corbett B.A., Mendoza S.P., Baym C.L., Bunge S.A., Levine S. Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome. Psychoneuroendocrinology 2008, 33:810-820.
36. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Current Opinion in Neurobiology 2007, 17(1):43-52.
37. Crane J., Fagerness J., Osiecki L., Gunnell B., Stewart S.E., Pauls D.L., Scharf J.M. Family-based genetic association study of DLGAP3 in Tourette Syndrome. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2011, 156B(1):108-114. Tourette Syndrome International Consortium for Genetics (TSAICG).
38. Crawford F.C., Ait-Ghezala G., Morris M., Sutcliffe M.J., Hauser R.A., Silver A.A., Mullan M.J. Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Human Genetics 2003, 113:154-161.
39. Cruz C., Camarena B., King N., Páez F., Sidenberg D., de la Fuente J.R., Nicolini H. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics?. Neuroscience Letters 1997, 231(1):1-4.
40. Cubo E., Fernández Jaén A., Moreno C., Anaya B., González M., Kompoliti K. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Clinical Therapeutics 2008, 30:182-189.
41. Cuker A., State M.W., King R.A., Davis N., Ward D.C. Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. American Journal of Medical Genetics Part A 2004, 130A(1):37-39.
42. Curtis D., Robertson M.M., Gurling H.M. Autosomal dominant gene transmission in a large kindred with Gilles de la Tourette syndrome. British Journal of Psychiatry 1992, 160:845-849.
43. Curtis D., Brett P., Dearlove A.M., McQuillin A., Kalsi G., Robertson M.M., Gurling H.M. Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatric Genetics 2004, 14(2):83-87.
44. Dehning S., Müller N., Matz J., Bender A., Kerle I., Benninghoff J., Musil R., Spellmann I., Bondy B., Möller H.J., Riedel M., Zill P. A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome. Psychiatric Genetics 2010, 20(1):35-38.
45. Dehning S., Riedel M., Müller N. Father-to-son transmission of 6;17 translocation in Tourette's syndrome. American Journal of Psychiatry 2008, 165(8):1051-1052.
46. Deng H., Gao K., Jankovic J. The genetics of Tourette syndrome. Nature Reviews Neurology 2012, 8(4):203-213.
47. Deng H., Le W.D., Xie W.J., Jankovic J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome?. Acta Neurologica Scandinavica 2006, 114(6):400-402.
48. Devor E.J., Magee H.J. Multiple childhood behavioral disorders (Tourette syndrome, multiple tics, ADD and OCD) presenting in a family with a balanced chromosome translocation (t1;8)(q21.1;q22.1). Psychiatric Genetics 1999, 9(3):149-151.
49. Devor E.J., Grandy D.K., Civelli O., Litt M., Burgess A.K., Isenberg K.E., van de Wetering B.J., Oostra B. Genetic linkage is excluded for the D2-dopamine receptor lambda HD2G1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome?. Human Heredity 1990, 40(2):105-108.
50. Devor E.J., Dill-Devor R.M., Magee H.J. The Bal I and Msp I polymorphisms in the dopamine D3 receptor gene display, linkage disequilibrium with each other but no association with Tourette syndrome. Psychiatric Genetics 1998, 8(2):49-52.
51. Diaz-Anzaldua A., Joober R., Riviere J.B., Dion Y., Lesperance P., Richer F., Chouinard S., Rouleau G.A. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Molecular Psychiatry 2004, 9:272-277. Montreal Tourette Syndrome Study Group.
52. Díaz-Anzaldúa A., Joober R., Rivière J.B., Dion Y., Lespérance P., Chouinard S., Richer F., Rouleau G.A. Association between 7q31 markers and Tourette syndrome. American Journal of Medical Genetics Part A 2004, 127A(1):17-20.
53. Donnai D. Gene location in Tourette syndrome. Lancet 1987, 1(8533):627.
54. Eapen V., Pauls D.L., Robertson M.M. Evidence for autosomal dominant transmission in Tourette's syndrome. United Kingdom cohort study. British Journal of Psychiatry 1993, 162:593-596.
55. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'arcy M., deBerardinis R., Frackelton E., Kim C., Lantieri F., Muganga B.M., Wang L., Takeda T., Rappaport E.F., Grant S.F., Berrettini W., Devoto M., Shaikh T.H., Hakonarson H., White P.S. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Molecular Psychiatry 2010, 15(6):637-646.
56. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489(7414):57-74. ENCODE Project Consortium.
57. Ercan-Sencicek A.G., Stillman A.A., Ghosh A.K., Bilguvar K., O'Roak B.J., Mason C.E., Abbott T., Gupta A., King R.A., Pauls D.L., Tischfield J.A., Heiman G.A., Singer H.S., Gilbert D.L., Hoekstra P.J., Morgan T.M., Loring E., Yasuno K., Fernandez T., Sanders S., Louvi A., Cho J.H., Mane S., Colangelo C.M., Biederer T., Lifton R.P., Gunel M., State M.W. l-Histidine decarboxylase and Tourette's syndrome?. New England Journal of Medicine 2010, 362(20):1901-1908.
58. Esbenshade T.A., Fox G.B., Cowart M.D. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Molecular Interventions 2006, 59(6):77-88.
59. Falivelli G., De Jaco A., Favaloro F.L., Kim H., Wilson J., Dubi N., Ellisman M.H., Abrahams B.S., Taylor P., Comoletti D. Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation. Human Molecular Genetics 2012, 21(21):4761-4773.
60. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1313-1323.
61. Feng R., Leckman J.F., Zhang H. Linkage analysis of ordinal traits for pedigree data. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(48):16739-16744.
62. Fernandez T.V., Sanders S.J., Yurkiewicz I.R., Ercan-Sencicek A.G., Kim Y.S., Fishman D.O., Raubeson M.J., Song Y., Yasuno K., Ho W.S., Bilguvar K., Glessner J., Chu S.H., Leckman J.F., King R.A., Gilbert D.L., Heiman G.A., Tischfield J.A., Hoekstra P.J., Devlin B., Hakonarson H., Mane S.M., Günel M., State M.W. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biological Psychiatry 2012, 71(5):392-402.
63. Feuk L., Kalervo A., Lipsanen-Nyman M., Skaug J., Nakabayashi K., Finucane B., Hartung D., Innes M., Kerem B., Nowaczyk M.J., Rivlin J., Roberts W., Senman L., Summers A., Szatmari P., Wong V., Vincent J.B., Zeesman S., Osborne L.R., Cardy J.O., Kere J., Scherer S.W., Hannula-Jouppi K. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia?. American Journal of Human Genetics 2006, 79(5):965-972.
64. Fragkouli A., van Wijk N.V., Lopes R., Kessaris N., Pachnis V. LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons. Development 2009, 136:3841-3851.
65. Freeman R.D. Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. European Child and Adolescent Psychiatry 2007, 16(Suppl. 1):15-23. Tourette Syndrome International Database Consortium.
66. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., Davis K.L., Silverman J.M., Brunner H.G., van Kessel A.G., Wijmenga C., Ophoff R.A., Veltman J.A. CNTNAP2 gene dosage variation is associated withschizophrenia and epilepsy?. Molecular Psychiatry 2008, 13(3):261-266.
67. Gade R., Muhleman D., Blake H., MacMurray J., Johnson P., Verde R., Saucier G., Comings D.E. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Molecular Psychiatry 1998, 3(1):50-60.
68. Gelernter J., Pakstis A.J., Pauls D.L., Kurlan R., Gancher S.T., Civelli O., Grandy D., Kidd K.K. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. Archives of General Psychiatry 1990, 47(11):1073-1077.
69. Gelernter J., Kennedy J.L., Grandy D.K., Zhou Q.Y., Civelli O., Pauls D.L., Pakstis A., Kurlan R., Sunahara R.K., Niznik H.B., et al. Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor?. American Journal of Psychiatry 1993, 150(3):449-453.
70. Gelernter J., Pauls D.L., Leckman J., Kidd K.K., Kurlan R. D2 dopamine receptor alleles do not influence severity ofTourette's syndrome? Results from four large kindreds. Archives of Neurology 1994, 51(4):397-400.
71. Ghanizadeh A., Mosallaei S. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome. Brain and Development 2009, 31(1):15-19.
72. Girirajan S., Brkanac Z., Coe B.P., Baker C., Vives L., Vu T.H., Shafer N., Bernier R., Ferrero G.B., Silengo M., Warren S.T., Moreno C.S., Fichera M., Romano C., Raskind W.H., Eichler E.E. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genetics 2011, 7(November (11)):e1002334.
73. Grados M.A. The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49(8):810-819. 819.e1-2.
74. Grice D.E., Leckman J.F., Pauls D.L., Kurlan R., Kidd K.K., Pakstis A.J., Chang F.M., Buxbaum J.D., Cohen D.J., Gelernter J. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome by the transmission-disequilibrium test. American Journal of Human Genetics 1996, 59(3):644-652.
75. Guo Y., Su L., Zhang J., Lei J., Deng X., Xu H., Yang Z., Kuang S., Tang J., Luo Z., Deng H. Analysis of the BTBD9 and HTR2C variants in Chinese Han patients with Tourette syndrome. Psychiatric Genetics 2012, 22(6):300-303.
76. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiological Reviews 2008, 88:1183-1241.
77. Hanna G.L., Veenstra-VanderWeele J., Cox N.J., Boehnke M., Himle J.A., Curtis G.C., Leventhal B.L., Cook E.H. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. American Journal of Medical Genetics 2002, 114(5):541-552.
78. Harris K., Singer H.S. Tic disorders: neural circuits neurochemistry, and neuroimmunology. Journal of Child Neurology 2006, 21(8):678-689.
79. Hasstedt S.J., Leppert M., Filloux F., van de Wetering B.J., McMahon W.M. Intermediate inheritance of Tourette syndrome assuming assortative mating. American Journal of Human Genetics 1995, 57(3):682-689.
80. Hebebrand J., Klug B., Fimmers R., et al. Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. Journal of Psychiatric Research 1997, 31:519-530.
81. Hebebrand J., Nöthen M.M., Ziegler A., Klug B., Neidt H., Eggermann K., Lehmkuhl G., Poustka F., Schmidt M.H., Propping P., Remschmidt H. Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome?. American Journal of Human Genetics 1997, 61(1):238-239.
82. Herzberg I., Valencia-Duarte A.V., Kay V.A., White D.J., Müller H., Rivas I.C., Mesa S.C., Cuartas M., García J., Bedoya G., Cornejo W., Ruiz-Linares A., Kremeyer B. Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate?. Psychiatric Genetics 2010, 20(4):179-183.
83. Hornyak M., Feige B., Riemann D., Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence clinical significance and treatment. Sleep Medicine Reviews 2006, 10(3):169-177.
84. Hutcheson H.B., Bradford Y., Folstein S.E., et al. Defining the autism minimum candidate gene region on chromosome 7. American Journal of Medical Genetics 2003, 117B:90-96.
85. Hyde T.M., Aaronson B.A., Randolph C., Rickler K.C., Weinberger D.R. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992, 42(3 Pt 1):652-658.
86. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Human Molecular Genetics 1998, 7:571-578. International Molecular Genetic Study of Autism Consortium.
87. Jamain S., Quach H., Betancur C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics 2003, 34:27-29.
88. Jankovic J., Deng H. Candidate locus for chorea and tic disorders at 15q?. Pediatric Neurology 2007, 37(1):70-73.
89. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13307-13312.
90. Karagiannidis I., Rizzo R., Tarnok Z., Wolanczyk T., Hebebrand J., Nöthen M.M., Lehmkuhl G., Farkas L., Nagy P., Barta C., Szymanska U., Panteloglou G., Miranda D.M., Feng Y., Sandor P., Barr C., Paschou P. Replication of association between a SLITRK1 haplotype and Tourette syndrome in a large sample of families. Molecular Psychiatry 2012, 17(7):665-668. TSGeneSEE.
91. Kataoka Y., Kalanithi P.S., Grantz H., Schwartz M.L., Saper C., Leckman J.F., Vaccarino F.M. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. Journal of Comparative Neurology 2010, 518:277-291.
92. Keen-Kim D., Mathews C.A., Reus V.I., Lowe T.L., Herrera L.D., Budman C.L., Gross-Tsur V., Pulver A.E., Bruun R.D., Erenberg G., Naarden A., Sabatti C., Freimer NB Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Human Molecular Genetics 2006, 15(22):3324-3328.
93. Kidd K.K., Pauls D.L. Genetic hypotheses for Tourette syndrome. Advances in Neurology 1982, 35:243-249.
94. Kerbeshian J., Severud R., Burd L., Larson L. Peek-a-boo fragile site at 16d associated with Tourette syndrome, bipolar disorder, autistic disorder, and mental retardation. American Journal of Medical Genetics 2000, 96(1):69-73.
95. Knight S., Coon H., Johnson M., Leppert M.F., Camp N.J., McMahon W.M. Linkage analysis of Tourette syndrome in a large Utah pedigree. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2010, 153B(2):656-662. Tourette Syndrome Association International Consortium for Genetics.
96. Knight D., Xie W., Boulianne G.L. Neurexins and neuroligins: recent insights from invertebrates. Molecular Neurobiology 2011, 44(December (3)):426-440.
97. Kroisel P.M., Petek E., Emberger W., Windpassinger C., Wladika W., Wagner K. Candidate region for Gilles de la Tourette syndrome at 7q31. American Journal of Medical Genetics 2001, 101:259-261.
98. Kubota Y., Ito C., Sakurai E., Sakurai E., Watanabe T., Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. Journal of Neurochemistry 2002, 83(4):837-845.
99. Kurlan R., Eapen V., Stern J., McDermott M.P., Robertson M.M. Bilineal transmission in Tourette's syndrome families?. Neurology 1994, 44(12):2336-2342.
100. Kurlan R., McDermott M.P., Deeley C., Como P.G., Brower C., Eapen S., Andresen E.M., Miller B. Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001, 57:1383-1388.
101. Kurlan R., Como P.G., Miller B., Palumbo D., Deeley C., Andresen E.M., Eapen S., McDermott M.P. The behavioral spectrum of tic disorders: a community-based study?. Neurology 2002, 59(3):414-420.
102. Lai C.S., Fisher S.E., Hurst J.A., Vargha-Khadem F., Monaco A.P. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001, 413:519-523.
103. Laumonnier F., Bonnet-Brilhault F., Gomot M., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American Journal of Human Genetics 2004, 74:552-557.
104. Laurin N., Wigg K.G., Feng Y., Sandor P., Barr C.L. Chromosome 5 and Gilles de la Tourette syndrome: linkage in a large pedigree and association study of six candidates in the region. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2009, 150B(1):95-103.
105. Lavenstein B.L. Treatment approaches for children with Tourette's syndrome. Current Neurology and Neuroscience Reports 2003, 3(2):143-148.
106. Lawson-Yuen A., Saldivar J.S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome?. European Journal of Human Genetics 2008, 16(5):614-618.
107. Leckman J.F., Riddle M.A. Tourette's syndrome: when habit-forming systems form habits of their own?. Neuron 2000, 28(2):349-354.
108. Lee C.C., Chou I.C., Tsai C.H., Wang T.R., Li T.C., Tsai F.J. Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome?. Pediatric Neurology 2005, 33(4):272-276.
109. Lei J., Deng X., Zhang J., Su L., Xu H., Liang H., Huang X., Song Z., Deng H. Mutation screening of the HDC gene in Chinese Han patients with Tourette syndrome. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2012, 159B(1):72-76.
110. Leppert M., Peiffer A., Snyder B., van de Wetering B.J.M., Filloux F., Coon H., McMahon W.M. Two loci of interest in a family with Tourette syndrome. American Journal of Human Genetics 1996, Suppl 59:A225.
111. Leslie D.L., Kozma L., Martin A., Landeros A., Katsovich L., King R.A., Leckman J.F. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children?. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47(10):1166-1172.
112. Lin H., Katsovich L., Ghebremichael M., et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry and Allied Disciplines 2006, 48:157-166.
113. Liodis P., Denaxa M., Grigoriou M., Akufo-Addo C., Yanagawa Y., Pachnis V. Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. Journal of Neuroscience 2007, 27:3078-3089.
114. Liu S.G., Zhang X.H., Yin Y.Y., Wang M.J., Che F.Y., Ma X. An association analysis between 5-HTTLPR polymorphism and obsessive-compulsive disorder Tourette syndrome in a Chinese Han population. CNS Neuroscience & Therapeutics 2011, 17(6):793-795.
115. Lu B., Poirier C., Gaspar T., Gratzke C., Harrison W., Busija D., Matzuk M.M., Andersson K.E., Overbeek P.A., Bishop C.E. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biology of Reproduction 2008, 78(4):601-610.
116. Ma Y., Mehta S.L., Lu B., Li P.A. Deficiency in the inner mitochondrial membrane peptidase 2-like (Immp21) gene increases ischemic brain damage and impairsmitochondrial function?. Neurobiology of Disease 2011, 44(3):270-276.
117. Maestrini E., Pagnamenta A.T., Lamb J.A., Bacchelli E., Sykes N.H., Sousa I., Toma C., Barnby G., Butler H., Winchester L., Scerri T.S., Minopoli F., Reichert J., Cai G., Buxbaum J.D., Korvatska O., Schellenberg G.D., Dawson G., de Bildt A., Minderaa R.B., Mulder E.J., Morris A.P., Bailey A.J., Monaco A.P. High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Molecular Psychiatry 2010, 15(9):954-968. IMGSAC.
118. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
119. Martino D., Dale R.C., Gilbert D.L., Giovannoni G., Leckman J.F. Immunopathogenic mechanisms in tourette syndrome: a critical review. Movement Disorders 2009, 24(9):1267-1279.
120. Mathews C.A., Grados M.A. Familiality of Tourette syndrome obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50(1):46-54.
121. Matsumoto N., David D.E., Johnson E.W., Konecki D., Burmester J.K., Ledbetter D.H., Weber J.L. Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome. European Journal of Human Genetics 2000, 8(11):875-883.
122. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics 2008, 9(5):356-369.
123. McMahon W.M., van de Wetering B.J., Filloux F., Betit K., Coon H., Leppert M. Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree?. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35(5):672-680.
124. Mell L.K., Davis R.L., Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005, 116(1):56-60.
125. Mérette C., Brassard A., Potvin A., Bouvier H., Rousseau F., Emond C., Bissonnette L., Roy M.A., Maziade M., Ott J., Caron C. Significant linkage for Tourette syndrome in a large French Canadian family. American Journal of Human Genetics 2000, 67(4):1008-1013.
126. Miranda D.M., Wigg K., Kabia E.M., Feng Y., Sandor P., Barr C.L. Association of SLITRK1 to Gilles de la Tourette syndrome. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2009, 150B(4):483-486.
127. Mol Debes N.M., Hjalgrim H., Skov L. Limited knowledge of Tourette syndrome causes delay in diagnosis. Neuropediatrics 2008, 39(2):101-105.
128. Mössner R., Walitza S., Geller F., Scherag A., Gutknecht L., Jacob C., Bogusch L., Remschmidt H., Simons M., Herpertz-Dahlmann B., Fleischhaker C., Schulz E., Warnke A., Hinney A., Wewetzer C., Lesch K.P. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 2006, 9:437-442.
129. Mössner R., Müller-Vahl K.R., Döring N., Stuhrmann M. Role of the novel tryptophan hydroxylase-2 gene in Tourette syndrome. Molecular Psychiatry 2007, 12:617-619.
130. Newbury D.F., Monaco A.P. Genetic advances in the study of speech and language disorders. Neuron 2010, 68(2):309-320.
131. Nöthen M.M., Hebebrand J., Knapp M., Hebebrand K., Camps A., von Gontard A., Wettke-Schäfer R., Lisch S., Cichon S., Poustka F., et al. Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method. American Journal of Medical Genetics 1994, 54(3):249-252.
132. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Molecular Psychiatry 2011, 16(3):286-292. International Schizophrenia Consortium, (Epub 2010 February).
133. O'Roak B.J., Morgan T.M., Fishman D.O., Saus E., Alonso P., Gratacòs M., Estivill X., Teltsh O., Kohn Y., Kidd K.K., Cho J., Lifton R.P., State M.W. Additional support for the association of SLITRK1 var321 and Tourette syndrome. Molecular Psychiatry 2010, 15(5):447-450. (Epub 2010 March 30).
134. Ozbay F., Wigg K.G., Turanli E.T., Asherson P., Yazgan Y., Sandor P., Barr C.L. Analysis of the dopamine beta hydroxylase gene in Gilles de laTourette syndrome. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2006, 141B(6):673-677.
135. Pagnamenta A.T., Bacchelli E., de Jonge M.V., Mirza G., Scerri T.S., Minopoli F., Chiocchetti A., Ludwig K.U., Hoffmann P., Paracchini S., Lowy E., Harold D.H., Chapman J.A., Klauck S.M., Poustka F., Houben R.H., Staal W.G., Ophoff R.A., O'Donovan M.C., Williams J., Nöthen M.M., Schulte-Körne G., Deloukas P., Ragoussis J., Bailey A.J., Maestrini E., Monaco A.P. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biological Psychiatry 2010, 68(August (4)):320-328. International Molecular Genetic Study Of Autism Consortium.
136. Pakstis A.J., Heutink P., Pauls D.L., Kurlan R., van de Wetering B.J., Leckman J.F., Sandkuyl L.A., Kidd J.R., Breedveld G.J., Castiglione C.M., et al. Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome?. American Journal of Human Genetics 1991, 48(2):281-294.
137. Paschou P., Feng Y., Pakstis A.J., Speed W.C., DeMille M.M., Kidd J.R., Jaghori B., Kurlan R., Pauls D.L., Sandor P., Barr C.L., Kidd K.K. Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. American Journal of Human Genetics 2004, 75:545-560.
138. Paschou P., Stylianopoulou E., Karagiannidis I., Rizzo R., Tarnok Z., Wolanczyk T., Hebebrand J., Nöthen M.M., Lehmkuhl G., Farkas L., Nagy P., Szymanska U., Lykidis D., Androutsos C., Tsironi V., Koumoula A., Barta C., Klidonas S., Ypsilantis P., Simopoulos C., Skavdis G., Grigoriou M. Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome. Genes, Brain, and Behavior 2012, 11(4):444-451. TSGeneSEE Consortium.
139. Patel C., Cooper-Charles L., McMullan D.J., Walker J.M., Davison V., Morton J. Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome?. European Journal of Human Genetics 2011, 19(6):634-639.
140. Pauls D.L., Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors? Evidence for autosomal dominant transmission. New England Journal of Medicine 1986, 315(16):993-997.
141. Pauls D.L., Raymond C.L., Stevenson J.M., Leckman J.F. A family study of Gilles de la Tourette syndrome. American Journal of Human Genetics 1991, 48(1):154-163.
142. Peñagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147(1):235-246.
143. Petek E., Windpassinger C., Vincent J.B., Cheung J., Boright A.P., Scherer S.W., Kroisel P.M., Wagner K. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. American Journal of Human Genetics 2001, 68:848-858.
144. Petek E., Windpassinger C., Vincent J.B., Cheung J., Boright A.P., Scherer S.W., Kroisel P.M., Wagner K. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome?. American Journal of Human Genetics 2001, 68(4):848-858.
145. Petek E., Schwarzbraun T., Noor A., Patel M., Nakabayashi K., Choufani S., Windpassinger C., Stamenkovic M., Robertson M.M., Aschauer H.N., Gurling H.M., Kroisel P.M., Wagner K., Scherer S.W., Vincent J.B. Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome?. Molecular Genetics and Genomics 2007, 277(1):71-81.
146. Peterson B.S., Thomas P., Kane M.J., Scahill L., Zhang H., Bronen R., et al. Basal ganglia volumes in patients with gilles de la tourette syndrome. Archives of General Psychiatry 2003, 60:415-424.
147. Poliak S., Salomon D., Elhanany H., Sabanay H., Kiernan B., Pevny L., Stewart C.L., Xu X., Chiu S.Y., Shrager P., Furley A.J., Peles E. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. Journal of Cell Biology 2003, 162:1149-1160.
148. Poot M., Beyer V., Schwaab I., Damatova N., Van't Slot R., Prothero J., Holder S.E., Haaf T. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 2010, 11(1):81-89.
149. Price R.A., Kidd K.K., Cohen D.J., Pauls D.L., Leckman J.F. A twin study of Tourette syndrome. Archives of General Psychiatry 1985, 42(8):815-820.
150. Proenca C.C., Gao K.P., Shmelkov S.V., Rafii S., Lee F.S. Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends in Neurosciences 2011, 34(3):143-153.
151. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends in Genetics 2001, 17:502-510.
152. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
153. Rivière J.B., Xiong L., Levchenko A., St-Onge J., Gaspar C., Dion Y., Lespérance P., Tellier G., Richer F., Chouinard S., Rouleau G.A. Association of intronic variants of the BTBD9 gene with Tourette syndrome. Archives of Neurology 2009, 66(10):1267-1272. Montreal Tourette Study Group.
154. Rivière J.B., St-Onge J., Gaspar C., Diab S., Dion Y., Lespérance P., Tellier G., Richer F., Chouinard S., Dubé M.P., Rouleau G.A. Genome-wide TDT analysis in French-Canadian families with Tourette syndrome. Canadian Journal of Neurological Sciences 2010, 37(1):110-112. Montreal Tourette Study Group.
155. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. Journal of Psychosomatic Research 2008, 65:461-472.
156. Robertson M.M., Orth M. Behavioral and affective disorders in Tourette syndrome. Advances in Neurology 2006, 99:39-60.
157. Roessner V., Becker A., Banaschewski T., Freeman R.D., Rothenberger A. Developmental psychopathology of children and adolescents with Tourette syndrome - impact of ADHD. European Child and Adolescent Psychiatry 2007, 16(Suppl. 1):24-35. Tourette Syndrome International Database Consortium.
158. Rowe D.C., Stever C., Gard J.M., Cleveland H.H., Sanders M.L., Abramowitz A., Kozol S.T., Mohr J.H., Sherman S.L., Waldman I.D. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behavior Genetics 1998, 28(3):215-225.
159. Saka E., Graybiel A.M. Pathophysiology of Tourette's syndrome: striatal pathways revisited. Brain and Development 2003, 25(Suppl. 1):S15L 9.
160. Samuels J., Wang Y., Riddle M.A., Greenberg B.D., Fyer A.J., McCracken J.T., Rauch S.L., Murphy D.L., Grados M.A., Knowles J.A., Piacentini J., Cullen B., Bienvenu O.J., Rasmussen S.A., Geller D., Pauls D.L., Liang K.Y., Shugart Y.Y., Nestadt G. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2011, 156B(4):472-477.
161. Scharf J.M., Moorjani P., Fagerness J., Platko J.V., Illmann C., Galloway B., Jenike E., Stewart S.E., Pauls D.L. Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 2008, 70(16 Pt 2):1495-1496. Tourette Syndrome International Consortium for Genetics.
162. Scharf, J.M., Yu, D., Mathews, C.A., et al. Genome-wide association study of Tourette's syndrome. Molecular Psychiatry, in press [Epub ahead of print].
163. Seuchter S.A., Hebebrand J., Klug B., Knapp M., Lehmkuhl G., Poustka F., Schmidt M., Remschmidt H., Baur M.P. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genetic Epidemiology 2000, 18(1):33-47.
164. Shelley B.P., Robertson M.M., Turk J. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes?. Journal of Intellectual Disability Research 2007, 51(Pt 8):620-624.
165. Shugart Y.Y., Wang Y., Samuels J.F., Grados M.A., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., Rasmussen S.A., Cullen B., Hoehn-Saric R., Pinto A., Fyer A.J., Piacentini J., Pauls D.L., Bienvenu O.J., Riddle M.A., Liang K.Y., Nestadt G. A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2009, 150B(6):886-892.
166. Silver A.A., Shytle R.D., Sheehan K.H., Sheehan D.V., Ramos A., Sanberg P.R. Multicenter double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(9):1103-1110.
167. Simonic I., Gericke G.S., Ott J., Weber J.L. Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population. American Journal of Human Genetics 1998, 63(3):839-846.
168. Simonic I., Nyholt D.R., Gericke G.S., Gordon D., Matsumoto N., Ledbetter D.H., Ott J., Weber J.L. Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11 8q22 and 11q23-24 in South African Afrikaners. American Journal of Medical Genetics 2001, 105(2):163-167.
169. Singer H.S., Minzer K. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain and Development 2003, 25(Suppl. 1):S70-S84.
170. Singh D.N., Howe G.L., Jordan H.W., Hara S. Tourette's syndrome in a black woman with associated triple X and 9p mosaicism. Journal of the National Medical Association 1982, 74(7):675-682.
171. Sowell E.R., Kan E., Yoshii J., Thompson P.M., Bansal R., Xu D., Toga A.W., Peterson B.S. Thinning of sensorimotor cortices in children with Tourette syndrome. Nature Neuroscience 2008, 11(6):637-639.
172. Speed W.C., O'Roak B.J., Tárnok Z., Barta C., Pakstis A.J., State M.W., Kidd K.K. Haplotype evolution of SLITRK1, a candidate gene for Gilles de la Tourette Syndrome. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2008, 147B(4):463-466.
173. State M.W. The genetics of child psychiatric disorders: focus on autism and Tourette syndrome?. Neuron 2010, 68(2):254-269.
174. State M.W., Greally J.M., Cuker A., Bowers P.N., Henegariu O., Morgan T.M., Gunel M., DiLuna M., King R.A., Nelson C., Donovan A., Anderson G.M., Leckman J.F., Hawkins T., Pauls D.L., Lifton R.P., Ward D.C. Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4684-4689.
175. Stein M.B., Yang B.Z., Chavira D.A., Hitchcock C.A., Sung S.C., Shipon-Blum E., Gelernter J. A common genetic variant in the neurexin superfamily memberCNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits?. Biological Psychiatry 2011, 69(9):825-831.
176. Stewart, S.E., Yu, D., Scharf, J.M., et al. Genome-wide association study of obsessive-compulsive disorder. Molecular Psychiatry, in press [Epub ahead of print].
177. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2?. New England Journal of Medicine 2006, 354(13):1370-1377.
178. Sundaram S.K., Huq A.M., Wilson B.J., Chugani H.T. Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 2010, 74(20):1583-1590.
179. Sundaram S.K., Huq A.M., Sun Z., Yu W., Bennett L., Wilson B.J., Behen M.E., Chugani H.T. Exome sequencing of a pedigree with Tourette syndrome or chronic tic disorder. Annals of Neurology 2011, 69(5):901-904.
180. Swain J.E., Scahill L., Lombroso P.J., King R.A., Leckman J.F. Tourette syndrome and tic disorders: a decade of progress. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:947-968.
181. Taylor L.D., Krizman D.B., Jankovic J., Hayani A., Steuber P.C., Greenberg F., Fenwick R.G., Caskey C.T. 9p monosomy in a patient with Gilles de la Tourette'ssyndrome. Neurology 1991, 41(9):1513-1515.
182. Tarnok Z., Ronai Z., Gervai J., Kereszturi E., Gadoros J., Sasvari-Szekely M., Nemoda Z. Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2007, 144:900-905.
183. Thompson M., Comings D.E., Feder L., George S.R., O'Dowd B.F. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients?. American Journal of Medical Genetics 1998, 81(3):241-244.
184. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. American Journal of Human Genetics 1999, 65:1428-1436. The Tourette Syndrome Association International Consortium for Genetics.
185. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. American Journal of Human Genetics 2007, 80:265-272. The Tourette Syndrome Association International Consortium for Genetics.
186. Turjanski N., Lees A.J., Brooks D.J. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999, 52(5):932-937.
187. Ueda S., Fujimoto S., Hiramoto K., Negishi M., Katoh H. Dock4 regulates dendritic development in hippocampal neurons. Journal of Neuroscience Research 2008, 86:3052-3061.
188. Verkerk A.J., Mathews C.A., Joosse M., Eussen B.H., Heutink P., Oostra B.A. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82:1-9. Tourette Syndrome Association International Consortium for Genetics.
189. Verkerk A.J., Cath D.C., van der Linde H.C., Both J., Heutink P., Breedveld G., Aulchenko Y.S., Oostra B.A. Genetic and clinical analysis of a large Dutch Gilles de laTourette family. Molecular Psychiatry 2006, 11(10):954-964.
190. Walkup J.T., LaBuda M.C., Singer H.S., Brown J., Riddle M.A., Hurko O. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance?. American Journal of Human Genetics 1996, 59(3):684-693.
191. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299:76.
192. Warburton P., Baird G., Chen W., Morris K., Jacobs B.W., Hodgson S., Docherty Z. Support for linkage of autism and specific language impairment to 7q3 from two chromosome rearrangements involving band 7q31?. American Journal of Medical Genetics 2000, 96(2):228-234.
193. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., Feliciano C., Chen M., Adams J.P., Luo J., Dudek S.M., Weinberg R.J., Calakos N., Wetsel W.C., Feng G. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice?. Nature 2007, 448(7156):894-900.
194. Wendland J.R., Kruse M.R., Murphy D.L. Functional SLITRK1 var321 varCDfs and SLC6A4 G56A variants and susceptibility to obsessive-compulsive disorder. Molecular Psychiatry 2006, 11(9):802-804.
195. Wendland J.R., Moya P.R., Timpano K.R., Anavitarte A.P., Kruse M.R., Wheaton M.G., Ren-Patterson R.F., Murphy D.L. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder?. Archives of General Psychiatry 2009, 66(4):408-416.
196. Willour V.L., Yao Shugart Y., Samuels J., Grados M., Cullen B., Bienvenu O.J., Wang Y., Liang K.Y., Valle D., Hoehn-Saric R., Riddle M., Nestadt G. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. American Journal of Human Genetics 2004, 75(3):508-513.
197. Xu X., Brookes K., Chen C.K., Huang Y.S., Wu Y.Y., Asherson P. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry 2007, 7:10.
198. Yan J., Oliveira G., Coutinho A., et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Molecular Psychiatry 2005, 10:329-332.
199. Yoon D.Y., Rippel C.A., Kobets A.J., Morris C.M., Lee J.E., Williams P.N., Bridges D.D., Vandenbergh D.J., Shugart Y.Y., Singer H.S. Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2007, 144:605-610.
200. Young S.E., Smolen A., Corley R.P., Krauter K.S., DeFries J.C., Crowley T.J., Hewitt J.K. Dopamine transporter polymorphism associated with externalizing behavior problems in children. American Journal of Medical Genetics 2002, 114:144-149.
201. Zhang H., Leckman J.F., Pauls D.L., Tsai C.P., Kidd K.K., Campos M.R. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. American Journal of Human Genetics 2002, 70(4):896-904. Tourette Syndrome Association International Consortium for Genetics.
202. Zhao Y., Marín O., Hermesz E., Powell A., Flames N., Palkovits M., Rubenstein J.L., Westphal H. The LIM-homeobox gene Lhx8 is required for the development of many cholinergic neurons in the mouse forebrain. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9005-9010.
203. Zimprich A., Hatala K., Riederer F., Stogmann E., Aschauer H.N., Stamenkovic M. Psychiatric Genetics 2008, 18(6):308-309.
204. Zuchner S., Cuccaro M.L., Tran-Viet K.N., Cope H., Krishnan R.R., Pericak-Vance M.A., Wright H.H., Ashley-Koch A. SLITRK1 mutations in trichotillomania?. Molecular Psychiatry 2006, 11(10):887-889.
205. Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B., et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. American Journal of Human Genetics 2009, 85:655-666.